| scholarly article | Q13442814 |
| P2093 | author name string | Seunghee Kang | |
| Hyunsuk Shim | |||
| Ke Liang | |||
| Zhongxing Liang | |||
| Younghyoun Yoon | |||
| Joann Brooks | |||
| Margaret Willard | |||
| P2860 | cites work | Involvement of chemokine receptors in breast cancer metastasis | Q24290909 |
| Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors | Q24320033 | ||
| VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms | Q28141270 | ||
| Tumorigenesis and the angiogenic switch | Q29619849 | ||
| Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer | Q29622818 | ||
| VEGF and the quest for tumour angiogenesis factors | Q34932327 | ||
| Silencing of CXCR4 blocks breast cancer metastasis | Q37074006 | ||
| Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. | Q37594844 | ||
| Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression | Q38329502 | ||
| The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity | Q40023447 | ||
| Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha | Q40271040 | ||
| Activated Neu/ErbB-2 induces expression of the vascular endothelial growth factor gene by functional activation of the transcription factor Sp 1. | Q40526897 | ||
| Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. | Q40543795 | ||
| Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis | Q40548697 | ||
| Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. | Q40554412 | ||
| Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. | Q40583161 | ||
| The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. | Q40780948 | ||
| Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. | Q42818347 | ||
| Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite | Q44249791 | ||
| Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck | Q45050425 | ||
| Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A. | Q48342270 | ||
| Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. | Q51716343 | ||
| The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. | Q53387393 | ||
| Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines | Q68839289 | ||
| Building better vasculature | Q74582167 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 716-722 | |
| P577 | publication date | 2007-06-04 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway | |
| P478 | volume | 359 |
| Q26800288 | A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma |
| Q64950548 | Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer. |
| Q41763265 | Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. |
| Q34051950 | Angiogenesis and its targeting in rheumatoid arthritis |
| Q49912722 | Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis. |
| Q51741248 | Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives. |
| Q37632152 | Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer |
| Q36019622 | Attenuation of cartilage pathogenesis in post-traumatic osteoarthritis (PTOA) in mice by blocking the stromal derived factor 1 receptor (CXCR4) with the specific inhibitor, AMD3100 |
| Q38913258 | Brain metastasis in lung cancer: Building a molecular and systems-level understanding to improve outcomes |
| Q50100841 | Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis |
| Q55000030 | C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3. |
| Q42183259 | CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment |
| Q38209604 | CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis |
| Q36415915 | CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study |
| Q34476278 | CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells |
| Q37826381 | CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target |
| Q38472331 | CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks |
| Q36132472 | CXCR4 gene transfer prevents pressure overload induced heart failure |
| Q42007327 | CXCR4 in Cancer and Its Regulation by PPARgamma |
| Q42033255 | CXCR4 knockdown inhibits the growth and invasion of nasopharyngeal cancer stem cells |
| Q37001222 | CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis. |
| Q34069720 | CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy |
| Q55122201 | Cancer stem cells as key drivers of tumour progression. |
| Q37351199 | Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors |
| Q33909030 | Chemokines and angiogenesis in rheumatoid arthritis. |
| Q34051768 | Chemokines and chemokine receptors in arthritis |
| Q93001507 | Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers |
| Q94571104 | Clinical Significance of C-X-C Motif Chemokine Receptor 4 and Integrin αvβ6 Expression in Breast Cancer |
| Q35149583 | Co-treatment with therapeutic neural stem cells expressing carboxyl esterase and CPT-11 inhibit growth of primary and metastatic lung cancers in mice |
| Q35166644 | Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. |
| Q35118166 | Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer |
| Q59652154 | Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis |
| Q36212626 | Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library |
| Q27305638 | Development of a unique small molecule modulator of CXCR4 |
| Q38443408 | Differential expressions of stromal cell-derived factor-1α and vascular endothelial growth factor in the placental bed of pregnancies complicated by preeclampsia |
| Q34414241 | Dipyrimidine Amines: A Novel Class of Chemokine Receptor Type 4 Antagonists with High Specificity |
| Q38763609 | Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer |
| Q33778134 | Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo |
| Q38722731 | Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells |
| Q34541713 | Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway |
| Q89468836 | Enhanced Neurogenesis and Collaterogenesis by Sodium Danshensu Treatment After Focal Cerebral Ischemia in Mice |
| Q37374575 | Enhanced neurogenesis and cell migration following focal ischemia and peripheral stimulation in mice |
| Q40675626 | Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions |
| Q38693302 | Extracellular Ubiquitin: Role in Myocyte Apoptosis and Myocardial Remodeling |
| Q33656526 | Extracellular ubiquitin increases expression of angiogenic molecules and stimulates angiogenesis in cardiac microvascular endothelial cells |
| Q38087291 | Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma. |
| Q37285629 | Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. |
| Q47174627 | G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts |
| Q60921607 | GPCR Modulation in Breast Cancer |
| Q37350419 | Genetic models of cancer in zebrafish |
| Q89218028 | HDAC9 overexpression confers invasive and angiogenic potential to triple negative breast cancer cells via modulating microRNA-206 |
| Q28744167 | HIV tropism and decreased risk of breast cancer |
| Q35828537 | Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells. |
| Q34009778 | Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells |
| Q48761162 | High expression of C-X-C chemokine receptor 4 and Notch1 is predictive of lymphovascular invasion and poor prognosis in lung adenocarcinoma |
| Q37248461 | Immunological mechanisms affecting angiogenesis and their relation to porcine pregnancy success |
| Q33907157 | Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis |
| Q35924203 | Inhibited experimental corneal neovascularization by neutralizing anti-SDF-1α antibody |
| Q35088560 | Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis |
| Q34071950 | Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression |
| Q52683626 | Inhibitors of HIF-1α and CXCR4 Mitigate the Development of Radiation Necrosis in Mouse Brain. |
| Q64121327 | Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice |
| Q38235254 | Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis |
| Q36271326 | Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling |
| Q64932805 | Intranasal administration of nerve growth factor promotes angiogenesis via activation of PI3K/Akt signaling following cerebral infarction in rats. |
| Q41819222 | Intravitreal Poly(L-lactide) Microparticles Sustain Retinal and Choroidal Delivery of TG-0054, a Hydrophilic Drug Intended for Neovascular Diseases |
| Q33891809 | Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. |
| Q28388722 | Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells |
| Q36983319 | Macrophages and chemokines as mediators of angiogenesis |
| Q36673955 | MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation |
| Q27324791 | Mobilization of endogenous bone marrow derived endothelial progenitor cells and therapeutic potential of parathyroid hormone after ischemic stroke in mice |
| Q52647550 | Mobilization of progenitor cells and assessment of vessel healing after second generation drug-eluting stenting by optical coherence tomography. |
| Q37355817 | Modulation of chemokine receptor activity through dimerization and crosstalk |
| Q55077069 | Myocardial Ischemia and Mobilization of Circulating Progenitor Cells. |
| Q38080032 | Neuronal restoration following ischemic stroke: influences, barriers, and therapeutic potential |
| Q92425093 | Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4 |
| Q50870345 | Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study. |
| Q35083529 | Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1. |
| Q38808628 | Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell |
| Q95725200 | Osteopontin b and c Splice isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance |
| Q28083668 | Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain |
| Q64092524 | Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma |
| Q82279431 | Phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 (P-Rex-1), a guanine nucleotide exchange factor for Rac, mediates angiogenic responses to stromal cell-derived factor-1/chemokine stromal cell derived factor-1 (SDF-1/CXCL-12) linked |
| Q34901360 | Phytochemistry and medicinal properties of Phaleria macrocarpa (Scheff.) Boerl. extracts |
| Q94526733 | Plasma exo-hsa_circRNA_0056616: A potential biomarker for lymph node metastasis in lung adenocarcinoma |
| Q36486011 | Plasma stromal cell-derived factor 1α/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease. |
| Q39969637 | Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells. |
| Q28567974 | RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans |
| Q34362205 | Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells. |
| Q39595415 | Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line |
| Q37148392 | Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN |
| Q45752215 | Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma |
| Q35105027 | Seminal Levels of Pro-inflammatory (CXCL1, CXCL9, CXCL10) and Homeostatic (CXCL12) Chemokines in Men With Asymptomatic Chlamydia trachomatis Infection. |
| Q27026113 | Slit/Robo pathway: a promising therapeutic target for cancer |
| Q38681163 | Spatiotemporal presentation of exogenous SDF-1 with PLGA nanoparticles modulates SDF-1/CXCR4 signaling axis in the rodent cortex. |
| Q44251054 | Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy |
| Q37998467 | Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg Ischaemia |
| Q64244049 | Support of Tumor Endothelial Cells by Chemokine Receptors |
| Q39493595 | Suppression of breast cancer proliferation and induction of apoptosis via AKT and ERK1/2 signal transduction pathways by synthetic polypeptide derived from viral macrophage inflammatory protein II. |
| Q33709960 | Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation |
| Q39108577 | Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cells. |
| Q41527702 | Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4. |
| Q92637513 | Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis |
| Q47850217 | Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy |
| Q36747524 | Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases |
| Q37577890 | Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus |
| Q38855031 | Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck |
| Q90018072 | The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy |
| Q90647016 | The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer |
| Q36562896 | The Role of chemokine receptor CXCR4 in breast cancer metastasis |
| Q90050404 | The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases |
| Q84071183 | The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome |
| Q55463049 | The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. |
| Q40282294 | The chemokine receptor CXCR4 promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis programme. |
| Q35858991 | The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer |
| Q51742979 | The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer |
| Q37394981 | The good and the bad of chemokines/chemokine receptors in melanoma |
| Q42737221 | The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer |
| Q38203241 | The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions |
| Q33993124 | The role of chemoattractant receptors in shaping the tumor microenvironment. |
| Q33907274 | The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation |
| Q37742024 | The role of the chemokine receptor XCR1 in breast cancer cells |
| Q90027887 | Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells |
| Q26777880 | Therapies targeting cancer stem cells: Current trends and future challenges |
| Q92126841 | Tumor Angiogenic Inhibition Triggered Necrosis (TAITN) in Oral Cancer |
| Q33934735 | Vascular Robo4 restricts proangiogenic VEGF signaling in breast |
| Q55114533 | cxcl12-engineered endothelial progenitor cells enhance neurogenesis and angiogenesis after ischemic brain injury in mice. |
| Q36068725 | miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis. |
Search more.